Difference between revisions of "Team:Paris Bettencourt/Active Testing"

Line 49: Line 49:
  
 
<div class="text3 img">
 
<div class="text3 img">
<img src="https://2018.igem.org/File:T--Paris_Bettencourt--_GC_Ecoli_A_2.png">
+
<img src="https://static.igem.org/mediawiki/2018/8/85/T--Paris_Bettencourt--_GC_Ecoli_A_2.png">
 
<img src="https://static.igem.org/mediawiki/2018/8/81/T--Paris_Bettencourt--_GC_Bsub_B_2.png">
 
<img src="https://static.igem.org/mediawiki/2018/8/81/T--Paris_Bettencourt--_GC_Bsub_B_2.png">
 
</div>
 
</div>

Revision as of 13:39, 6 December 2018


Active Testing

Following the production phase of our project, we had 10 StarCore constructs to test. We set out to characterize their antimicrobial properties and mechanism of action. We had many questions in the following categories.

  • Antimicrobial activity: Do they kill bacteria? What is their effective concentration?
  • Specificity: Do they selectively kill certain types of bacteria?
  • Mechanism of action: How do they kill the bacteria?
  • Toxicity: How toxic are they to human cells?
  • Geometry: Does the structure of a StarCore change the function?
  • Results

    StarCores kill bacteria at micromolar concentrations

    We evaluated the impact of StarCores on bacterial growth by treating bacterial cultures with the fusion proteins and monitoring the OD 600 through time. Representative results are shown in Fig. 1.

    Fig. 1. Growth curves of E. coli (A) and B. subtilis (B) in the presence of StarCores.

    We also quantified their antimicrobial activity by determining the minimum inhibitory concentrations (MIC). Ovispirin, a commonly used antimicrobial peptide (AMP) with no star-shaped geometry, was used as a control in every experiment. The results of the MIC determination are summarized in Table 1.

    Centre for Research and Interdisciplinarity (CRI)
    Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
    Paris Descartes University
    24, rue du Faubourg Saint Jacques
    75014 Paris, France
    paris-bettencourt-2018@cri-paris.org